EGFR overexpression or mutations are frequently observed in cancer types such as non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), colorectal cancer, gastric cancer and breast cancer [23]. Here, EGFR is linked to non-small cell lung carcinoma.